101 related articles for article (PubMed ID: 4538396)
1. Influence of normal human serum on the determination of trichomonicidal drug concentrations.
Forsgren A
Br J Vener Dis; 1972 Jun; 48(3):205-6. PubMed ID: 4538396
[No Abstract] [Full Text] [Related]
2. Sensitivity of Trichomonas vaginalis to chemotherapeutic agents.
Paredes FR; Hawkins DF
J Obstet Gynaecol Br Commonw; 1973 Jan; 80(1):86-8. PubMed ID: 4540495
[No Abstract] [Full Text] [Related]
3. [Application of a method of intraperitoneal infestation of the mouse, by Trichomonas vaginalis, for the pharmacologic study of trichomonacides].
Cavier R; Gobert JG; Savel J
Ann Pharm Fr; 1972 Sep; 30(9):637-42. PubMed ID: 4541136
[No Abstract] [Full Text] [Related]
4. [Studies on the velocity of action of trichomonocidal drugs].
Broccali G; De Carneri I
Ginecol Obstet Mex; 1971 Nov; 30(181):481-90. PubMed ID: 5316160
[No Abstract] [Full Text] [Related]
5. Induction of in-vivo resistance of trichomonas vaginalis to nitrimidazine.
Benazet F; Guillaume L
Lancet; 1971 Oct; 2(7731):982-3. PubMed ID: 4107939
[No Abstract] [Full Text] [Related]
6. Studies on antiprotozoans. 3. Isolation, identification and quantitative determination in humans of the metabolites of a new trichomonacidal agent.
Giraldi PN; Tosolini GP; Dradi E; Nannini G; Longo R; Meinardi G; Monti G; de Carneri I
Biochem Pharmacol; 1971 Feb; 20(2):339-49. PubMed ID: 5317098
[No Abstract] [Full Text] [Related]
7. The pharmacokinetics of metronidazole and tinidazole in man.
Welling PG; Monro AM
Arzneimittelforschung; 1972 Dec; 22(12):2128-32. PubMed ID: 4679183
[No Abstract] [Full Text] [Related]
8. [In vitro sensitivity of 50 Trichomonas vaginalis strains to CP 12 574].
Kremer M; Miltgen F; Dellenbach P
Rev Fr Gynecol Obstet; 1972 Nov; 67(11):655-7. PubMed ID: 4540771
[No Abstract] [Full Text] [Related]
9. [Characteristics of the action of nitrimidazine (nimorazol), a new systemic trichomonacidal agent. I. Microbiological study].
De Carneri I; Cantone A; Emanueli A; Giraldi PN; Logemann W; Longo R; Meinardi G; Monti G; Nannini G; Tosolini G; Trane F; Vita G
Boll Chim Farm; 1972 Jul; 111(7):393-408. PubMed ID: 4538708
[No Abstract] [Full Text] [Related]
10. Antiparasitic nitroimidazoles. IV. Serum protein binding and mode of action of 2-(4'-carboxystyryl)-5-nitro-1-vinylimidazole.
Tarrant ME; Wedley S; Woodage TJ; Green JN
Biochem Pharmacol; 1973 Mar; 22(5):639-49. PubMed ID: 4348117
[No Abstract] [Full Text] [Related]
11. [Physical-chemical properties and antitrichomonal effect of 2-, 4-, and 5-nitroimidazoles].
Sunjić V; Kajfez F; Kolbah D; Blazević N
Pharmazie; 1972 Mar; 27(3):131-8. PubMed ID: 4558978
[No Abstract] [Full Text] [Related]
12. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
[TBL] [Abstract][Full Text] [Related]
13. Setting a colorimetric assay with MTT for assessment of trichomonicidal activity.
Sariego I; Monzote L; Rojas L
Curr Clin Pharmacol; 2014; 9(3):283-7. PubMed ID: 23173972
[TBL] [Abstract][Full Text] [Related]
14. Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation.
Forsgren A; Wallin J
Br J Vener Dis; 1974 Apr; 50(2):146-7. PubMed ID: 4546971
[No Abstract] [Full Text] [Related]
15. [Studies on the susceptibility of Trichomonas hominis to some abiotic factors. I. Preliminary assessment of antitrichomonal activity of selected compounds in vitro].
Chomicz L; Zebrowska J; Zawadzki P; Myjak P; Perkowski K; Rebandel H; Kazimierczuk Z
Wiad Parazytol; 2004; 50(3):405-9. PubMed ID: 16865945
[TBL] [Abstract][Full Text] [Related]
16. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
He Y; Tao X; Guan L; Lian W
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
[TBL] [Abstract][Full Text] [Related]
17. The selective toxicity of antimicrobial nitroheterocyclic drugs.
Edwards DI; Dye M; Carne H
J Gen Microbiol; 1973 May; 76(1):135-45. PubMed ID: 4541833
[No Abstract] [Full Text] [Related]
18. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Schwebke JR; Barrientes FJ
Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
[TBL] [Abstract][Full Text] [Related]
19. [Trichomonacidal and amebicidal properties of flunidazole, (hydroxy-2' ethyl)-1 (p. fluorophenyl) 2-nitro 5-imidazole)].
Cavier R; Cenac J
Therapie; 1972; 27(4):733-42. PubMed ID: 4538856
[No Abstract] [Full Text] [Related]
20. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
